Diagnosis and classification of Crohn's disease

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 467-471

  Laass, Martin W ^a   Roggenbuck, Dirk ^b,c   Conrad, Karsten ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b BRANDENBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^c GA GENERIC ASSAYS GMBH   (Germany)

Author keywords

Autoantibody; Crohn's disease; Diagnostic criteria; Inflammatory bowel diseases; Ulcerative colitis

Indexed keywords

GLYCOPROTEIN;

ADAPTIVE IMMUNITY; ARTHRITIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CROHN DISEASE; DELAYED PUBERTY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENDOSCOPY; ERYTHEMA NODOSUM; ETIOLOGY; FAILURE TO THRIVE; HUMAN; INCIDENCE; INTESTINE FLORA; MEDICAL HISTORY; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; RADIOLOGICAL PROCEDURES; REVIEW; SACCHAROMYCES CEREVISIAE; SERODIAGNOSIS; UVEITIS;

AUTOANTIBODY; CROHN'S DISEASE; DIAGNOSTIC CRITERIA; INFLAMMATORY BOWEL DISEASES; ULCERATIVE COLITIS;

BIOLOGICAL MARKERS; COLONOSCOPY; CROHN DISEASE; HUMANS; INCIDENCE; PREVALENCE; RECURRENCE;

EID: 84896318771     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.029     Document Type: Review

References (36)

1. Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142:46-54.
2. Baumgart D.C., Sandborn W.J. Crohn's disease. Lancet 2012, 380:1590-1605.
3. Khor B., Gardet A., Xavier R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474:307-317.
4. Baumgart D.C., Metzke D., Schmitz J., Scheffold A., Sturm A., Wiedenmann B., et al. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 2005, 54:228-236.
5. Franke A., McGovern D.P., Barrett J.C., Wang K., Radford-Smith G.L., Ahmad T., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010, 42:1118-1125.
6. Jostins L., Ripke S., Weersma R.K., Duerr R.H., McGovern D.P., Hui K.Y., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491:119-124.
7. Clevers H. Inflammatory bowel disease, stress, and the endoplasmic reticulum. N Engl J Med 2009, 360:726-727.
8. Glocker E.O., Kotlarz D., Boztug K., Gertz E.M., Schäffer A.A., Noyan F., et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009, 361:2033-2045.
9. Jung C., Colombel J.-F., Lemann M., Beaugerie L., Allez M., et al. Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphisms. PLoS One 2012, 7:e52223. 10.1371/journal.pone.0052223.
10. Cleynen I., González J.R., Figueroa C., Franke A., McGovern D., Bortlík M., et al. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project. Gut 2012, [Published Online First]. 10.1136/gutjnl-2011- 300777.
11. Logan I., Bowlus C.L. The geoepidemiology of autoimmune intestinal disease. Autoimmun Rev 2010, 9:A372-A378.
12. Walker J.E. Possible diagnostic test for Crohn's disease by use of buccal mucosa. Lancet 1978, 2:759-760.
13. Stöcker W., Otte M., Ulrich S., Normann D., Stöcker K., Jantschek G. Autoantikörper gegen exokrines Pankreas und gegen intestinale Becherzellen in der Diagnostik des Morbus Crohn und der Colitis ulcerosa. Dt med Wschr 1984, 109:1963-1969.
14. Roggenbuck D., Hausdorf G., Martinez-Gamboa L., Reinhold D., Büttner T., Jungblut P.R. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease. Gut 2009, 58:1620-1628.
15. Hase K., Kawano K., Nochi T., Pontes G.S., Fukuda S., Ebisawa M., et al. Uptake through glycoprotein 2 of FimH+bacteria by M cells initiates mucosal immune response. Nature 2009, 462:226-230.
16. Werner L., Paclik D., Fritz C., Reinhold D., Roggenbuck D., Sturm A. Identification of pancreatic glycoprotein 2 as an endogenous immunomodulator of innate and adaptive immune responses. J Immunol 2012, 189:2774-2783.
17. Van Assche G., Dignass A., Panes J., Beaugerie L., Karagiannis J., Allez M., et al. European Crohn's and Colitis Organisation (ECCO). The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010, 4:7-27.
18. Schirbel A., Reichert A., Roll S., Baumgart D.C., Buning C., Wittig B., et al. Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol 2010, 16:3168-3177.
19. Vavricka S.R., Brun L., Ballabeni P., et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011, 106:110-119.
20. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989, 170:2-6.
21. Tolan D.J., Greenhalgh R., Zealley I.A., Halligan S., Taylor S.A. MR enterographic manifestations of small bowel Crohn disease. Radiographics 2010, 30:367-384.
22. Pearce M.S., Salotti J.A., Little M.P., McHugh K., Lee C., Kim K.P., et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012, 380:499-505.
23. Peyrin-Biroulet L., Loftus E.V., Colombel J.F., Sandborn W.J. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010, 105:289-297.
24. Thia K.T., Sandborn W.J., Harmsen W.S., Zinsmeister A.R., Loftus E.V. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 2010, 139:1147-1155.
25. Van Limbergen J., Russell R.K., Drummond H.E., Aldhous M.C., Round N.K., Nimmo E.R., et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008, 135:1114-1122.
26. Conrad K., Schmechta H., Klafki A., Lobeck G., Uhlig H., Gerdi S., et al. Serological differentiation of inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2002, 14:1-7.
27. Bossuyt X. Serologic markers in inflammatory bowel disease. Clin Chem 2006, 52:171-181.
28. Komorowski L., Teegen B., Probst C., Aulinger-Stöcker K., Sina C., Fellermann K., et al. Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2. J Crohns Colitis 2013, 7:780-790.
29. Bogdanos D.P., Rigopoulou E.I., Smyk D.S., Roggenbuck D., Reinhold D., Alastair Forbes A., et al. Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. Autoimmun Rev 2011, 11:143-148.
30. Li Xuhang, Conklin Laurie, Alex Philip New serological biomarkers of inflammatory bowel disease. World J Gastroenterol 2008, 14:5115-5124.
31. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
32. Levine A., Griffiths A., Markowitz J., Wilson D.C., Turner D., Russell R.K., et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011, 17:1314-1321.
33. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
34. Harvey R.F., Bradshaw J.M. A simple index of Crohn's-disease activity. Lancet 1980, 1:514.
35. Turner D., Griffiths A.M., Walters T.D., Seah T., Markowitz J., Pfefferkorn M., et al. Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties. Am J Gastroenterol 2010, 105:2085-2092.
36. Magro F., Langner C., Driessen A., Ensari A., Geboes K., Mantzaris G.J., et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013, 7:827-851.